Asensus Surgical

Asensus Surgical ROCE

Delisted

The Return on Capital Employed (ROCE) of Asensus Surgical (ASXC) as of Oct 22, 2026 is -233.82 %. In the previous year, Return on Capital Employed (ROCE) was -75.95 % — a change of 207.87% (lower).

ROCE

-233.82 %

YoY

207.87%

Last updated:

In 2023, Asensus Surgical's return on capital employed (ROCE) was -233.82 %, a 207.87% increase from the -75.95 % ROCE in the previous year.

The Asensus Surgical ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2016
-104.90 USD
Jan 1, 2017
-34.63 USD
Jan 1, 2018
-37.00 USD
Jan 1, 2019
-278.34 USD
Jan 1, 2020
-98.08 USD
Jan 1, 2021
-38.18 USD
Jan 1, 2022
-75.95 USD
Jan 1, 2023
-233.82 USD
The Asensus Surgical ROCE history
YEARROCEYoY
-233.82 %+207.87%
-75.95 %+98.92%
-38.18 %-61.07%
-98.08 %-64.76%
-278.34 %+652.35%
-37.00 %+6.85%
-34.63 %-66.99%
-104.90 %+301.05%
-26.16 %-12.98%
-30.06 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Asensus Surgical Stock analysis

What does Asensus Surgical do? Asensus Surgical Inc is a medical technology company based in Research Triangle Park, North Carolina, USA. It was founded in 1995 by Joe Mussallem, who still serves as President and CEO today. Formerly known as "TransEnterix," the company changed its name to Asensus Surgical Inc in 2021 to reflect its commitment to advanced, data-driven surgery. Asensus Surgical Inc aims to revolutionize the way surgical procedures are performed by utilizing robotic technology and offering a wide range of products and services. The company's business model is based on transferring skills typically held by surgeons to robots, with a focus on precision in surgeries. Through the use of machine learning and computer vision, Asensus Surgical Inc allows surgeons to monitor their own movements in real-time on robotic arms in the operating room, leading to significantly more precise work. The company's main division is the Senhance® Surgical System platform. The system consists of three components: the artificial intelligence technology of the Intelligent Surgical Units (ISU), touchscreen consoles, and a further sterilization cabinet. During surgical procedures, the Intelligent Surgical Units process real-time data, enabling improved decision-making during the operation. The touchscreen consoles serve as the user interface, allowing surgeons to monitor and control the operation in real-time on a screen. The sterilization cabinet ensures that the system is sterilized between procedures. In addition to the Senhance® Surgical System platform, Asensus Surgical Inc also offers other innovative products such as disposable instruments. This includes "3-mm instruments," special miniature instruments that can be used through very small incisions in the patient's body. These minimize scarring and enable faster recovery. Another product offered by Asensus Surgical Inc is the AI Camera Assistant, which is based on artificial intelligence (AI). This is a computer software that supports surgeons by analyzing real-time images and enabling monitoring and analysis during the procedure. Combined with the Senhance® Surgical System, the AI Camera Assistant allows for more precise and safer work. Asensus Surgical Inc has achieved several significant milestones in its history. One of these milestones is the FDA approval of the Senhance® Surgical System platform in 2017. Furthermore, in 2020, the company entered into an agreement with Johnson & Johnson to advance the marketing of products. Overall, Asensus Surgical Inc is an emerging company in the highly innovative field of robotics in surgery. With its advanced products and focus on precise, safe, and straightforward surgery, the company will continue to play an important role in the healthcare industry, saving and improving lives. Asensus Surgical is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Asensus Surgical's Return on Capital Employed (ROCE)

Asensus Surgical's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Asensus Surgical's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Asensus Surgical's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Asensus Surgical’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Asensus Surgical stock

Return on Capital Employed (ROCE) of Asensus Surgical is -233.82 % in 2023.

Return on Capital Employed (ROCE) of Asensus Surgical changed from -75.95 % to -233.82 %, representing a 207.87% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Asensus Surgical since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Asensus Surgical with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Asensus Surgical

All Key Metrics — Asensus Surgical